MedTrace Logo

Evaluation of COPD Co-Pilot

NCT03018847 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 23

Last updated 2018-03-13

No results posted yet for this study

Summary

The purpose of undertaking this study is to examine the use of COPD Co-PilotTM, a COPD disease management program manufactured and operated by HGE Health Care Solutions, LLC, in COPD patients outside of the geographic base of HGE's existing patient population (Philadelphia, PA). The purpose is to demonstrate the feasibility of expanding the program to additional geographic sites and to examine whether similar outcome measures are achieved in patients under the supervision of health care providers that are new to the program.

.

Conditions

Interventions

DEVICE

COPD Co-Pilot

The COPD Co-Pilot is a system that guides a patient through a software application (web or mobile app) to collect, track, and trend daily symptoms related to Chronic Obstructive Pulmonary Disease (COPD). The system is intended to be used by patients as a support tool to track COPD symptoms as part of their personal disease management plan. The COPD Co-Pilot allows health care providers to view and triage subject symptoms via the provider web-based application. Health care providers also have the ability to send responses to subjects, like medication recommendations, through preset forms in the system.

Sponsors & Collaborators

  • PneumRx, Inc.

    collaborator INDUSTRY

  • HGE Health Care Solutions, LLC

    lead INDUSTRY

Principal Investigators

  • Tatsiana Beiko, MD · Medical University of South Carolina

Eligibility

Min Age
35 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-03-31
Completion
2018-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03018847 on ClinicalTrials.gov